Skip to content
SP

Sarda Proteins

FRESITA PROTEINS LIMITED

519242 BSE
₹122.50

Close ·

P/E
Not meaningful: last twelve months’ earnings are mostly a one-off item
View as Markdown
MCP
Close 4 Nov 2026 ₹122.50 +35.94 +41.5% 1Y
Start ₹86.56

Key Fundamentals

MicrocapConsumer GoodsFMCG

Price-based figures at the close · EPS basis: Standalone · TTM

ROCE
1.45%
Debt to Equity
0.00
EPS (TTM)
₹4.41
Book Value
₹107.55
Market Cap
—
P/E (TTM)
Not meaningful: last twelve months’ earnings are mostly a one-off item
P/B
1.14
ROE
1.02%
Dividend Yield
0.00%
EBITDA
₹60.00 L
52W High
₹174.65
52W Low
₹59.95

Key Insights

Strengths

1
  • Company is almost debt free.

Weaknesses

4
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 0.98% over last 3 years.
  • Earnings include an other income of Rs.5.83 Cr.
  • Working capital days have increased from 780 days to 1,729 days

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBullish829
OscillatorsStrong Bullish225
Moving AveragesStrong Bearish604

Key readings

RSI (14)
38.21
Neutral
MACD (12,26,9)
−2.39
Bearish
SMA (50)
128.75
Bearish
SMA (200)
100.53
Bullish

As of

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y+22.87%
5Y+7.30%
3Y+40.71%
1Y−33.17%
TTM−48.24%

Net profit

Net profit growth by window
10YTurned to profit
5YTurned to profit
3YTurned to profit
1YTiny base
TTMTurned to profit

Operating cash flow

Operating cash flow growth by window
10YOutflow widened by ₹75.16 Cr
5YOutflow widened by ₹76.31 Cr
3YOutflow widened by ₹76.06 Cr
1YOutflow widened by ₹76.25 Cr
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y+7.62 pp
5Y+1.97 pp
3Y+4.38 pp
1Y+1.71 pp
TTM−12.66 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹6.18 Cr
Mar 2018₹5.65 Cr
Mar 2019₹7.22 Cr
Mar 2020₹5.40 Cr
Mar 2021₹11.36 Cr
Mar 2022₹10.76 Cr
Mar 2023₹5.80 Cr
Mar 2024₹1.30 Cr
Mar 2025₹24.18 Cr
Mar 2026₹16.16 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017−₹0.13 Cr
Mar 2018−₹0.33 Cr
Mar 2019−₹0.12 Cr
Mar 2020₹0.03 Cr
Mar 2021−₹0.02 Cr
Mar 2022₹0.31 Cr
Mar 2023−₹0.03 Cr
Mar 2024₹0.02 Cr
Mar 2025₹0.01 Cr
Mar 2026₹0.45 Cr

Quarterly Results

₹ Cr
519242 quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0.24
0
1
0.06
0
0.14
24.05
0
10.95
4.3
0.25
0.65
12.99
Expenses
0.28
0.05
1.03
0.08
0.08
0.03
23.95
0.1
11.44
4.01
0.37
0.05
16.26
Operating Profit
−0.04
−0.05
−0.03
−0.02
−0.08
0.11
0.1
−0.1
−0.49
0.29
−0.12
0.6
−3.27
OPM %
−16.67%
—
−3%
−33.33%
—
78.57%
0.42%
—
−4.47%
6.74%
−48%
92.31%
−25.17%
Other Income
0.04
0.04
0.04
0.04
0
0
0
0
0
0.11
0
0.24
5.48
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0
−0.01
0.01
0.02
−0.08
0.11
0.1
−0.1
−0.49
0.4
−0.12
0.84
2.21
Tax %
—
0%
0%
0%
0%
0%
0%
20%
0%
0%
0%
0%
24.89%
Net Profit
0
−0.01
0.01
0.02
−0.08
0.11
0.1
−0.11
−0.49
0.4
−0.12
0.84
1.66
EPS (₹)
0
−0.06
0.06
0.12
−0.46
0.64
0.58
−0.64
−2.84
2.32
−0.7
0.94
1.85

Profit & Loss

₹ Cr
519242 profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
5.02
2.06
6.18
5.65
7.22
5.4
11.36
10.76
5.8
1.3
24.18
16.16
18.19
Expenses
5.14
2.18
6.35
6
7.33
5.31
11.38
10.5
5.95
1.45
24.16
15.87
20.69
Operating Profit
−0.12
−0.12
−0.17
−0.35
−0.11
0.09
−0.02
0.26
−0.15
−0.15
0.02
0.29
−2.5
OPM %
−2.39%
−5.83%
−2.75%
−6.19%
−1.52%
1.67%
−0.18%
2.42%
−2.59%
−11.54%
0.08%
1.79%
−13.74%
Other Income
0.8
0
0
−0.01
0.03
0.08
0.08
0.09
0.16
0.17
0
0.35
5.83
Interest
0.02
0.03
0.01
0
0
0
0
0
0
0
0
0
0
Depreciation
0.04
0.02
0.01
0.01
0.01
0
0
0
0
0
0
0
0
PBT
0.62
−0.17
−0.19
−0.37
−0.09
0.17
0.06
0.35
0.01
0.02
0.02
0.64
3.33
Tax %
4.84%
−5.88%
−31.58%
−10.81%
44.44%
82.35%
133.33%
14.29%
500%
0%
100%
28.12%
—
Net Profit
0.59
−0.15
−0.13
−0.33
−0.12
0.03
−0.02
0.31
−0.03
0.02
0.01
0.45
2.78
EPS (₹)
1.8
−0.87
−0.75
−1.91
−0.7
0.17
−0.12
1.8
−0.17
0.12
0.06
0.5
4.41
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
519242 balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
2.43
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
2.5
9.75
Reserves
0.3
0.15
0.02
−0.31
−0.44
−0.41
−0.43
−0.12
−0.15
−0.13
−0.13
76.45
Borrowings
0.21
0.61
0.2
0
0.01
0
0
0
0
0
0
0
Other Liabilities
0.2
0.21
0.2
0.13
0.12
0.06
0.07
0.07
0.05
0.07
0.27
0.45
Total Liabilities
3.14
3.47
2.92
2.32
2.19
2.15
2.14
2.45
2.4
2.44
2.64
86.65
Fixed Assets
0.1
0.06
0.05
0.03
0.02
0.01
0.01
0
0
0
0
0.01
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0.01
0.01
0.01
0.01
0
0
0
0
0
0
0
0
Other Assets
3.03
3.4
2.86
2.28
2.17
2.14
2.13
2.45
2.4
2.44
2.64
86.64
Total Assets
3.14
3.47
2.92
2.32
2.19
2.15
2.14
2.45
2.4
2.44
2.64
86.65

Cash Flow

₹ Cr
519242 cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
−0.72
−1.2
−0.09
0.48
−0.59
−0.05
−0.05
0.1
−0.3
−0.23
−0.11
−76.36
Investing
1.9
0.2
0
0.02
0.11
0.09
0.08
0.09
0.16
0.17
0
0.36
Financing
−0.13
0.37
−0.42
−0.2
0.01
−0.01
0
0
0
0
0.03
83.49
Net Cash Flow
1.05
−0.63
−0.51
0.3
−0.47
0.03
0.03
0.19
−0.14
−0.07
−0.08
7.49
Free Cash Flow
0.73
−1.18
−0.09
0.48
−0.59
−0.04
−0.05
0.1
−0.3
−0.23
−0.11
−76.35
CFO/EBITDA
525
1,000
53
−134
536
−22
200
38
200
153
−550
−26,331

Ratios

519242 financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
13.81
0
38.98
44.58
36.4
56.1
24.74
7.12
0
0
0
93.51
Inventory Days
32.7
324
64.41
28.64
0
0
0
0
0
0
0
0
Days Payable
0.76
0
0.61
0
—
—
—
—
—
—
—
—
Cash Conversion Cycle
45.75
324
103
73.22
36.4
56.1
24.74
7.12
0
0
0
93.51
Working Capital Days
65.44
252
108
76.23
83.92
115
55.91
64.45
130
604
5.89
1,729
ROCE %
−5.93%
−4.52%
−6.02%
−14.66%
−5.63%
8.17%
2.88%
15.73%
0.42%
0.85%
0.84%
1.45%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Sarda Proteins insights

57 extracted metrics across FY10–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 80.47%
  • Public 18.95%
  • Others 0.58%

No promoter shares pledged as of 14 Oct 2026

Change since Jun 2026

Documents

Frequently Asked Questions about Sarda Proteins

What does FRESITA PROTEINS LIMITED do?
Incorporated in 1991, Sarda Proteins Ltd deals in the trading of Solar Cells
Where is FRESITA PROTEINS LIMITED (FRESITA) listed?
FRESITA PROTEINS LIMITED trades under code 519242 on the BSE.
Which sector does FRESITA PROTEINS LIMITED belong to?
FRESITA PROTEINS LIMITED is classified under the FMCG sector, in the FMCG Products industry.
What is the 52-week high and low of FRESITA PROTEINS LIMITED?
Over the last 52 weeks FRESITA PROTEINS LIMITED has traded between ₹59.95 and ₹174.65 as of 4 Nov 2026.
What is the Return on Equity (ROE) of FRESITA PROTEINS LIMITED?
FRESITA PROTEINS LIMITED reported a return on equity of 1.02%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 1991, Sarda Proteins Ltd deals in the trading of Solar Cells

Website sardaproteins.in
Listed 4 Apr 2006
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/519242.md for FRESITA PROTEINS LIMITED: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Agri & Food Products stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month